These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16205476)

  • 41. Correlation of clinical and pathological findings in patients with lupus nephritis: a five-year experience in Iran.
    Nezhad ST; Sepaskhah R
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):32-40. PubMed ID: 18087120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Classifying lupus nephritis: an ongoing story.
    Kiremitci S; Ensari A
    ScientificWorldJournal; 2014; 2014():580620. PubMed ID: 25548784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rewriting the histological classification of lupus nephritis.
    Schwartz MM; Lewis EJ
    J Nephrol; 2002; 15 Suppl 6():S11-9. PubMed ID: 12515369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions.
    Wilhelmus S; Alpers CE; Cook HT; Ferrario F; Fogo AB; Haas M; Joh K; Noël LH; Seshan SV; Bruijn JA; Bajema IM
    J Am Soc Nephrol; 2015 Dec; 26(12):2938-46. PubMed ID: 26152271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classes, activity and chronicity indices, and alpha-smooth muscle actin expression as prognostic parameters in lupus nephritis outcome.
    Ravinal RC; Costa RS; Coimbra TM; Pastorello MT; Coelho EB; Dantas M; dos RM
    Lupus; 2002; 11(2):82-7. PubMed ID: 11958582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.
    Yu F; Haas M; Glassock R; Zhao MH
    Nat Rev Nephrol; 2017 Aug; 13(8):483-495. PubMed ID: 28669995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of urinary protein markers in lupus nephritis.
    Oates JC; Varghese S; Bland AM; Taylor TP; Self SE; Stanislaus R; Almeida JS; Arthur JM
    Kidney Int; 2005 Dec; 68(6):2588-92. PubMed ID: 16316334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcome of biopsy-proven lupus nephritis in Iran.
    Fatemi A; Kazemi M; Sayedbonakdar Z; Farajzadegan Z; Karimzadeh H; Moosavi M
    Int J Rheum Dis; 2013 Dec; 16(6):739-46. PubMed ID: 24267776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of the kidney biopsy in the treatment of lupus nephritis.
    Kashgarian M
    Ren Fail; 1996 Sep; 18(5):765-73. PubMed ID: 8903091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and histological features of lupus nephritis in Japan: A cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR).
    Hiromura K; Ikeuchi H; Kayakabe K; Sugiyama H; Nagata M; Sato H; Yokoyama H; Nojima Y
    Nephrology (Carlton); 2017 Nov; 22(11):885-891. PubMed ID: 27461874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
    Kim YG; Kim HW; Cho YM; Oh JS; Nah SS; Lee CK; Yoo B
    Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lupus nephritis. Clinicopathological correlation.
    Al-Zahrani IH; Qayyum A
    Saudi Med J; 2007 Oct; 28(10):1503-5. PubMed ID: 17914508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The predictive value of crescents in the disease progression of lupus nephritis based on the 2018 International Society of Nephrology/Renal Pathology Society Revision System: a large cohort study from China.
    Tao J; Wang H; Wang SX; Yu F; Zhao MH
    Ren Fail; 2020 Nov; 42(1):166-172. PubMed ID: 32054387
    [No Abstract]   [Full Text] [Related]  

  • 54. A clinico-pathological study of lupus nephritis based on the International Society of Nephrology-Renal Pathology Society 2003 classification system.
    Satish S; Deka P; Shetty MS
    J Lab Physicians; 2017; 9(3):149-155. PubMed ID: 28706383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in pathological pattern and treatment regimens based on repeat renal biopsy in lupus nephritis.
    Wang GB; Xu ZJ; Liu HF; Zhou QG; Zhou ZM; Jia N
    Chin Med J (Engl); 2012 Aug; 125(16):2890-4. PubMed ID: 22932086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pathological classification and clinical characteristics of lupus nephritis: a report of 49 cases].
    Liu Y; Yang HF; Wang LX
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1915-7. PubMed ID: 20813701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
    Nived O; Hallengren CS; Alm P; Jönsen A; Sturfelt G; Bengtsson AA
    Scand J Rheumatol; 2013; 42(5):383-9. PubMed ID: 23829689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lupus nephritis. Part I. Histopathological classification, activity and chronicity scores.
    Bates WD; Halland AM; Tribe RD; Rossouw DJ
    S Afr Med J; 1991 Mar; 79(5):256-9. PubMed ID: 2011804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification.
    Haas M; Rastaldi MP; Fervenza FC
    Kidney Int; 2014 Apr; 85(4):779-93. PubMed ID: 24088958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis.
    Olmes G; Büttner-Herold M; Ferrazzi F; Distel L; Amann K; Daniel C
    Arthritis Res Ther; 2016 Apr; 18():90. PubMed ID: 27091114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.